早期系统性硬化症患者报告结局测量工具的研发
COAST研究通过42例早期系统性硬化症(SSc)患者的概念引出访谈,构建了两个患者报告结局(PRO)测量工具:33条目的COAST硬皮病症状问卷和20条目的COAST硬皮病功能与情绪问卷,旨在用于临床试验评估早期SSc的治疗获益。
要点
- COAST研究开发了针对早期SSc的两个PRO测量工具,覆盖dcSSc和lcSSc亚型。
- 症状问卷含33条目,功能与情绪问卷含20条目,内容效度经系统患者输入确立。
- 雷诺现象是最常报告症状(81.0%),疲劳在最高频症状中困扰度最高(均值7.20,0-10量表)。
核心结论
- COAST测量工具填补了早期SSc患者报告结局测量的重要空白,内容效度通过系统患者输入确立,设计用于临床试验评估早期SSc治疗获益。
研究设计与样本
- COAST研究对42例发病7年内的dcSSc或lcSSc患者进行概念引出访谈,采用持续比较法分析数据,概念优先级整合症状频率、困扰度、健康相关生活质量评分、亚组分析和临床专家意见。
主要发现
- 患者报告了跨越16个领域的52种症状和治疗副作用,雷诺现象最常报告(81.0%),肿胀和疼痛各为66.7%;在五种最常报告症状中,疲劳困扰度最高(均值7.20,0-10量表)。
- 患者还报告了跨越8个领域的57项身体功能影响和跨越4个领域的16项社会情绪问题。
- 构建了两个候选测量工具:COAST硬皮病症状问卷(33条目)和COAST硬皮病功能与情绪问卷(20条目)。
关键数值与推荐
- 优先概念映射至PROMIS®、FACIT及SSc特异性测量工具的条目,测量工具精炼过程中开发新条目,条目池通过专家共识缩减。
临床怎么用
- COAST测量工具可用于临床试验中评估早期SSc(包括dcSSc和lcSSc亚型)的治疗获益,涵盖症状、身体功能和社会情绪维度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Existing patient-reported outcome (PRO) measures for systemic sclerosis (SSc) have important limitations, including inadequate coverage of early disease and limited inclusion of diffuse cutaneous (dcSSc) and limited cutaneous (lcSSc) subtypes. This paper reports on the development of two PRO measures for early SSc in the Clinical Outcome Assessments for Systemic Sclerosis Clinical Trials (COAST) study, following regulatory guidance for clinical outcome assessments. METHODS: Concept elicitation interviews were conducted with 42 individuals with dcSSc or lcSSc within 7 years of disease onset. Data were analyzed using a constant comparative approach. The concept prioritization scheme integrated symptom frequency, bother and health-related quality of life ratings, subgroup analyses, and clinical expert input. Priority concepts were mapped to items from item libraries (PROMIS®, FACIT) and SSc-specific measures, with new items developed during measure refinement. The item pool was reduced through expert consensus. RESULTS: Across SSc subtypes, participants reported 52 symptoms and treatment side effects, spanning 16 domains. Raynaud's phenomenon was the most frequently reported symptom (81.0%), followed by swelling and pain (66.7% each); among the five most frequently reported symptoms, fatigue was rated most bothersome (mean=7.20, 0-10 scale). Participants also reported 57 physical function impacts across 8 domains, and 16 socioemotional concerns across 4 domains. Two candidate measures were constructed: COAST Scleroderma Symptom Questionnaire (33 items) and COAST Scleroderma Function and Mood Questionnaire (20 items). CONCLUSIONS: The COAST measures address important gaps in SSc measurement, with content validity established through systematic patient input. The measures were designed for use in clinical trials to assess treatment benefit in early SSc.
引用
- Greene GJ, Perschon CR, Jaeger E, et al. Development of Patient-Reported Outcome Measures for Early Systemic Sclerosis Across Disease Subtypes. Arthritis Care Res (Hoboken). 2026. PMID: 42870706. doi:10.1002/acr.80190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。